Structurally characterized arabinogalactan from Anoectochilus formosanus as an immuno-modulator against CT26 colon cancer in BALB/c mice

Phytomedicine

Volumn 21, Issue 5, 2014, Pages 647-655

  Yang, Li Chan ^a   Hsieh, Chang Chi ^b   Lu, Ting Jang ^a   Lin, Wen Chuan ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TUNGHAI UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anoectochilus formosanus; Anti cancer; Arabinogalactan; Immuno modulator; Immunotherapy; Polysaccharide

Indexed keywords

ARABINOGALACTAN; CD69 ANTIGEN; CHEMOKINE; CXCL2 CHEMOKINE; CYTOKINE; FLUOROURACIL; INTERLEUKIN 1ALPHA; MITOGENIC AGENT; POLYSACCHARIDE; GALACTAN; IMMUNOLOGIC FACTOR; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOECTOCHILUS FORMOSANUS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; BODY WEIGHT; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CELL PROLIFERATION; CLINICAL EVALUATION; COLON CANCER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INNATE IMMUNITY; MEDICINAL PLANT; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; SPLEEN WEIGHT; TREATMENT DURATION; ANIMAL; CARCINOMA; CHEMISTRY; COLONIC NEOPLASMS; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION PROFILING; ISOLATION AND PURIFICATION; MACROPHAGE; MALE; METABOLISM; ORCHIDACEAE; PHYTOTHERAPY; RANDOMIZATION; SPLEEN;

ANOECTOCHILUS FORMOSANUS; MUS;

ANIMALS; BODY WEIGHT; CARCINOMA; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; GALACTANS; GENE EXPRESSION PROFILING; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; MACROPHAGES; MALE; MICE, INBRED BALB C; ORCHIDACEAE; PHYTOTHERAPY; PLANT EXTRACTS; RANDOM ALLOCATION; SPLEEN;

EID: 84898057127     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2013.10.032     Document Type: Article

References (36)

1. ®) in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer 2013 U. S. National Institutes of Health (ClinicalTrials.gov Identifier: NCT 01309126)
2. J.E. Blalock The immune system as a sensory organ J. Immunol. 132 1984 1067 1070
3. F. Borrego, M.J. Robertson, J. Ritz, J. Pena, and R. Solana CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor Immunology 97 1999 159 165
4. Y. Fujimoto, and T.F. Tedder CD83: a regulatory molecule of the immune system with great potential for therapeutic application J. Med. Dent. Sci. 53 2006 85 91
5. M. Goldstein, and S. Watkins Immunohistochemistry Curr. Protoc. Mol. Biol. 2008 (Chapter 14, Unit 14.16)
6. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899
7. C.V. Harding Choosing and preparing antigen-presenting cells Curr. Protoc. Immunol. 2001 (Chapter 16, Unit 16.1)
8. K. Hariharan, G. Braslawsky, A. Black, S. Raychaudhuri, and N. Hanna The induction of cytotoxic T cells and tumor regression by soluble antigen formulation Cancer Res. 55 1995 3486 3489
9. J. Hauer, and F.A. Anderer Mechanism of stimulation of human natural killer cytotoxicity by arabinogalactan from Larix occidentalis Cancer Immunol. Immunother. 36 1993 237 244
10. Y.H. Hsiang, R. Hertzberg, S. Hecht, and L.F. Liu Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I J. Biol. Chem. 260 1985 14873 14878
11. H.Y. Kim, J.H. Kim, S.B. Yang, S.G. Hong, S.A. Lee, S.J. Hwang, K.S. Shin, H.J. Suh, and M.H. Park A polysaccharide extracted from rice bran fermented with Lentinus edodes enhances natural killer cell activity and exhibits anticancer effects J. Med. Food 10 2007 25 31
12. Y. Kimura, and M. Sumiyoshi Effects of various Eleutherococcus senticosus cortex on swimming time, natural killer activity and corticosterone level in forced swimming stressed mice J. Ethnopharmacol. 95 2004 447 453
13. N. Kodama, A. Asakawa, A. Inui, Y. Masuda, and H. Nanba Enhancement of cytotoxicity of NK cells by D-fraction, a polysaccharide from Grifola frondosa Oncol. Rep. 13 2005 497 502
14. M.M.S. Kwajah, and H. Schwarz CD137 ligand signaling induces human monocyte to dendritic cell differentiation Eur. J. Immunol. 40 2010 1938 1949
15. H. Liu, Y. Fan, W. Wang, N. Liu, H. Zhang, Z. Zhu, and A. Liu Polysaccharides from Lycium barbarum leaves: isolation, characterization and splenocyte proliferation activity Int. J. Biol. Macromol. 51 2012 417 422
16. H. Lu, Y. Yang, E. Gad, C.A. Wenner, A. Chang, E.R. Larson, Y. Dang, M. Martzen, L.J. Standish, and M.L. Disis Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells Clin. Cancer Res. 17 2011 67 76
17. M. Lucas, W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach Dendritic cells prime natural killer cells by trans-presenting interleukin 15 Immunity 26 2007 503 517
18. Y. Masuda, H. Inoue, H. Ohta, A. Miyake, M. Konishi, and H. Nanba Oral administration of soluble beta-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice Int. J. Cancer 133 2013 108 119
19. I. Mellman, G. Coukos, and G. Dranoff Cancer immunotherapy comes of age Nature 480 2011 480 489
20. E. Meylan, J. Tschopp, and M. Karin Intracellular pattern recognition receptors in the host response Nature 442 2006 39 44
21. L.A. O'Neill Interleukin-1 signal transduction Int. J. Clin. Lab Res. 25 1995 169 177
22. C. Qi, Y. Cai, L. Gunn, C. Ding, B. Li, G. Kloecker, K. Qian, J. Vasilakos, S. Saijo, Y. Iwakura, J.R. Yannelli, and J. Yan Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived beta-glucans Blood 117 2011 6825 6836
23. L. Ren, C. Perera, and Y. Hemar Antitumor activity of mushroom polysaccharides: a review Food. Funct. 3 2012 1118 1130
24. +/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proc. Natl. Acad. Sci. U. S. A. 102 2005 18538 18543
25. N. Scholler, M. Hayden-Ledbetter, A. Dahlin, I. Hellstrom, K.E. Hellstrom, and J.A. Ledbetter Cutting edge: CD83 regulates the development of cellular immunity J. Immunol. 168 2002 2599 2602
26. L.F. Shyur, C.H. Chen, C.P. Lo, S.Y. Wang, P.L. Kang, S.J. Sun, C.A. Chang, C.M. Tzeng, and N.S. Yang Induction of apoptosis in MCF-7 human breast cancer cells by phytochemicals from Anoectochilus formosanus J. Biomed. Sci. 11 2004 928 939
27. R. Sullivan, J.E. Smith, and N.J. Rowan Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine Perspect. Biol. Med. 49 2006 159 170
28. G. Tarantino, S. Savastano, D. Capone, and A. Colao Spleen: a new role for an old player? World J. Gastroenterol. 17 2011 3776 3784
29. M.M. Tomayko, and C.P. Reynolds Determination of subcutaneous tumor size in athymic (nude) mice Cancer Chemother. Pharmacol. 24 1989 148 154
30. C.C. Tseng, H.F. Shang, L.F. Wang, B. Su, C.C. Hsu, H.Y. Kao, and K.T. Cheng Antitumor and immunostimulating effects of Anoectochilus formosanus Hayata Phytomedicine 13 2006 366 370
31. A.O. Tzianabos Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function Clin. Microbiol. Rev. 13 2000 523 533
32. R. van Horssen, T.L. Ten Hagen, and A.M. Eggermont TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility Oncologist 11 2006 397 408
33. P. Wang, S.M. Henning, and D. Heber Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols PLoS ONE 5 2010 e10202
34. M.C. Wani, H.L. Taylor, M.E. Wall, P. Coggon, and A.T. McPhail Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia J. Am. Chem. Soc. 93 1971 2325 2327
35. L.C. Yang, W.C. Lin, and T.J. Lu Characterization and prebiotic activity of aqueous extract and indigestible polysaccharide from Anoectochilus formosanus J. Agric. Food Chem. 60 2012 8590 8599
36. L. Zhang, J.R. Conejo-Garcia, D. Katsaros, P.A. Gimotty, M. Massobrio, G. Regnani, A. Makrigiannakis, H. Gray, K. Schlienger, M.N. Liebman, S.C. Rubin, and G. Coukos Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer N. Engl. J. Med. 348 2003 203 213